Evidence suggests that the presence of an amyloid precursor protein sequence in the IAPP molecule could increase the IAPP secretion from β-cells associated with the elevated insulin demand and abnormalities in the processing of pro-IAPP contribute to aggregation in T2DM, causing cellular dysfunction and subsequent membrane disruption, channel formation, and toxicity. The gene discussed is INS; the disease is type 2 diabetes mellitus.